VCEL Stock Price, Vericel Corp Quote, Chart

Market Summary

USD48.40-0.12

Market Closed

-0.25%

VCEL Alerts

1 major insider sales recently.

Big jump in Revenue (Y/Y)
Big jump in Earnings (Y/Y)
Losses in recent quarter

VCEL Stock Price

View Fullscreen

VCEL RSI Chart

VCEL Valuation

Market Cap

2.4B

Price/Earnings (Trailing)

5.7K

Price/Sales (Trailing)

11.35

EV/EBITDA

145.95

Price/Free Cashflow

1.2K

VCEL Price/Sales (Trailing)

VCEL Profitability

EBT Margin

4.92%

Return on Equity

0.18%

Return on Assets

0.12%

Free Cashflow Yield

0.09%

VCEL Fundamentals

VCEL Revenue

Revenue (TTM)

207.8M

Rev. Growth (Yr)

25.02%

Rev. Growth (Qtr)

-21.1%

VCEL Earnings

Earnings (TTM)

413.0K

Earnings Growth (Yr)

47.97%

Earnings Growth (Qtr)

-130.02%

Breaking Down VCEL Revenue

52 Week Range

31.2249.00

(Low)(High)

Last 7 days

3.5%

Last 30 days

1.4%

Last 90 days

5.7%

Trailing 12 Months

48.1%

How does VCEL drawdown profile look like?

VCEL Financial Health

Current Ratio

5.2

Debt/Equity

0.06

Debt/Cashflow

2.63

VCEL Investor Care

Shares Dilution (1Y)

2.18%

Diluted EPS (TTM)

0.01

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	207.8M	0	0	0
2023	169.3M	178.2M	185.2M	197.5M
2022	157.7M	155.2M	159.3M	164.4M
2021	132.1M	151.6M	153.8M	156.2M
2020	122.7M	116.6M	118.3M	124.2M
2019	94.6M	101.8M	109.8M	117.8M
2018	72.6M	74.6M	82.9M	90.9M
2017	56.5M	60.6M	63.9M	63.9M
2016	54.4M	53.7M	53.3M	61.2M
2015	39.6M	48.8M	50.5M	51.2M
2014	0	17.3M	23.0M	28.8M
2013	27.0K	30.0K	5.8M	11.5M
2012	11.0K	11.0K	2.0K	21.0K
2011	53.5K	41.7K	29.8K	18.0K
2010	0	89.0K	77.2K	65.3K
2009	0	182.0K	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Vericel Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 01, 2024	wotton paul k	acquired	-	-	3,200	-
May 01, 2024	wright lisa	acquired	-	-	3,200	-
May 01, 2024	mclaughlin kevin f	acquired	-	-	3,200	-
May 01, 2024	zerbe robert l md	acquired	-	-	3,200	-
May 01, 2024	rubino alan l	acquired	-	-	3,200	-
May 01, 2024	hagen heidi	acquired	-	-	3,200	-
May 01, 2024	gilman steven c	acquired	-	-	3,200	-
Apr 30, 2024	colangelo dominick	acquired	299,977	11.7892	25,445	president and ceo
Apr 18, 2024	colangelo dominick	acquired	52,850	3.02	17,500	president and ceo

Which funds bought or sold VCEL recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 10, 2024	PNC Financial Services Group, Inc.	reduced	-0.61	71,208	228,783	-%
May 10, 2024	Hillsdale Investment Management Inc.	added	8.42	2,295,270	6,226,220	0.49%
May 10, 2024	Campbell & CO Investment Adviser LLC	sold off	-100	-285,735	-	-%
May 10, 2024	CIBC Private Wealth Group, LLC	new	-	39,146	39,146	-%
May 10, 2024	MACKENZIE FINANCIAL CORP	new	-	204,126	204,126	-%
May 10, 2024	DIMENSIONAL FUND ADVISORS LP	reduced	-12.21	7,345,090	33,356,000	0.01%
May 10, 2024	BROWN BROTHERS HARRIMAN & CO	unchanged	-	14,933	47,338	-%
May 10, 2024	CITIGROUP INC	added	157	6,775,960	9,235,010	0.01%
May 10, 2024	Jackson Creek Investment Advisors LLC	new	-	1,165,000	1,165,000	0.42%
May 10, 2024	LPL Financial LLC	reduced	-17.01	80,831	461,573	-%

Are Funds Buying or Selling VCEL?

Are funds buying VCEL calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own VCEL

No. of Funds

Unveiling Vericel Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	brown capital management llc	14.29%	6,818,933	SC 13G/A
Feb 14, 2024	rtw investments, lp	6.7%	3,212,794	SC 13G/A
Feb 13, 2024	vanguard group inc	7.07%	3,374,093	SC 13G/A
Jan 25, 2024	state street corp	5.58%	2,664,883	SC 13G/A
Jan 22, 2024	blackrock inc.	16.6%	7,937,063	SC 13G/A
Jan 05, 2024	conestoga capital advisors, llc	5.23%	2,495,619	SC 13G/A
Feb 14, 2023	brown capital management llc	14.68%	6,931,641	SC 13G/A
Feb 14, 2023	rtw investments, lp	6.6%	3,099,904	SC 13G/A
Feb 09, 2023	state street corp	7.12%	3,364,203	SC 13G/A
Feb 09, 2023	vanguard group inc	7.00%	3,307,928	SC 13G/A

Recent SEC filings of Vericel Corp

View All Filings

Date Filed	Form Type	Document
May 08, 2024	10-Q	Quarterly Report
May 08, 2024	8-K	Current Report
May 03, 2024	4	Insider Trading
May 03, 2024	4	Insider Trading
May 03, 2024	4	Insider Trading
May 03, 2024	4	Insider Trading
May 03, 2024	4	Insider Trading
May 03, 2024	4	Insider Trading
May 03, 2024	4	Insider Trading
May 03, 2024	8-K	Current Report

Peers (Alternatives to Vericel Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
MRNA	48.2B	6.8B	19.54%	-2.80%	-8.07	7.03	-64.45%	-224.75%
HILS	22.5B	216.3K	-0.77%	465779.94%	-2.5K	104.0K	-	-8.13%
ALNY	19.0B	2.0B	0.98%	-26.98%	-57.12	9.47	75.20%	68.82%
BMRN	15.3B	2.5B	-12.72%	-14.31%	74.39	6.18	13.74%	186.89%
INCY	12.9B	3.8B	6.98%	-11.75%	17.35	3.43	8.58%	129.81%
MID-CAP
BBIO	5.3B	107.9M	6.22%	110.41%	-9.76	48.09	54.84%	-28.31%
APLS	5.2B	524.1M	-16.95%	-51.10%	-12.51	9.96	394.93%	39.61%
AXSM	3.6B	251.0M	9.36%	-4.29%	-12.12	14.31	73.58%	-86.73%
ARWR	2.7B	240.7M	-10.69%	-43.90%	-5.82	12.77	-1.03%	-213.43%
ACAD	2.5B	813.8M	-11.38%	-29.25%	-1.5K	3.08	56.43%	98.83%
SMALL-CAP
CPRX	1.9B	411.3M	6.64%	20.67%	29.44	4.66	60.38%	-34.49%
NVAX	1.8B	996.6M	206.31%	55.15%	-4.62	1.85	-26.66%	65.49%
CRBP	458.7M	881.7K	5.07%	336.18%	-13.59	481.06	-77.61%	33.36%
INO	294.6M	4.9M	3.08%	29.79%	-2.36	60.54	-54.97%	48.23%
IBIO	15.6M	2.1M	-10.40%	79.21%	-0.67	7.61	-13.45%	69.54%

Vericel Corp News

Latest updates

Vericel Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-21.1%	51,281	64,996	45,581	45,922	41,017	52,694	38,551	37,046	36,074	47,591	34,506	39,519	34,568	45,229	32,258	20,014	26,678	39,390	30,499	26,151	21,810
Gross Profit	-27.1%	35,354	48,507	30,608	29,941	26,520	38,249	25,233	22,854	23,452	34,032	22,098	26,910	22,985	33,647	22,471	11,354	16,756	28,805	21,175	17,129	13,170
Operating Expenses	14.1%	40,818	35,776	35,665	35,902	34,697	32,164	32,021	31,936	30,725	29,891	27,059	30,639	26,290	21,358	18,954	19,712	21,832	19,595	18,078	37,329	16,528
S&GA Expenses	11.4%	34,400	30,875	29,989	30,649	29,485	26,919	26,975	27,144	25,865	25,967	22,775	26,190	22,660	18,240	16,041	16,486	18,069	16,378	14,982	16,259	13,520
R&D Expenses	31.0%	6,418	4,901	5,676	5,253	5,212	5,245	5,046	4,792	4,860	3,924	4,284	4,449	3,630	3,118	2,913	3,226	3,763	3,217	3,096	21,070	3,008
EBITDA Margin	-3.5%	0.08*	0.08*	-0.04*	-0.06*	-0.07*	-0.07*	-0.09*	-0.09*	-0.05*	-0.03*	0.02*	0.08*	-	-	-	-	-	-	-	-	-
Interest Expenses	-1.9%	153	156	150	149	145	223	105	20.00	18.00	1.00	1.00	1.00	1.00	1.00	2.00	1.00	2.00	2.00	2.00	2.00	2.00
Income Taxes	-100.0%	-	1,100	-286	-	-	700	21.00	-	-	-326	-	72.00	143	180	-	-	-	-	-	-	-
Earnings Before Taxes	-100.0%	-	14,093	-3,946	-	-	6,622	-6,556	-8,963	-7,091	4,209	-4,931	-3,714	-3,146	12,400	3,618	-8,269	-4,705	-	-	-	-
EBT Margin	-4.9%	0.05*	0.05*	-0.07*	-0.09*	-0.09*	-0.10*	-0.12*	-0.11*	-0.07*	-0.05*	0.00*	0.06*	-	-	-	-	-	-	-	-	-
Net Income	-130.0%	-3,900	12,993	-3,660	-5,020	-7,495	5,922	-6,577	-8,963	-7,091	4,535	-4,931	-3,786	-3,289	12,220	3,618	-8,269	-4,705	9,501	3,470	-19,792	-2,844
Net Income Margin	112.3%	0.00*	-0.02*	-0.06*	-0.07*	-0.10*	-0.10*	-0.11*	-0.11*	-0.07*	-0.05*	0.00*	0.06*	-	-	-	-	-	-	-	-	-
Free Cashflow	-402.8%	-6,815	2,251	600	6,000	6,447	5,850	2,692	1,162	387	9,560	1,171	2,651	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	0.8%	357	354	318	311	265	273	248	245	240	244	224	222	211	206	158	147	150	153	138	126	141
Current Assets	-7.7%	190	206	186	183	178	187	166	155	152	158	145	139	127	124	125	116	117	112	105	94.00	110
Cash Equivalents	2.4%	71.00	69.00	60.00	43.00	62.00	51.00	65.00	56.00	56.00	68.00	55.00	52.00	58.00	34.00	44.00	56.00	46.00	27.00	37.00	14.00	35.00
Inventory	3.6%	14.00	13.00	13.00	14.00	15.00	16.00	17.00	16.00	14.00	13.00	13.00	13.00	10.00	9.00	10.00	8.00	7.00	7.00	7.00	5.00	4.00
Net PPE	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7.00	7.00	6.00
Liabilities	-3.9%	123	128	114	112	71.00	81.00	70.00	70.00	68.00	73.00	67.00	71.00	71.00	71.00	43.00	39.00	40.00	42.00	41.00	37.00	38.00
Current Liabilities	-20.3%	36.00	46.00	36.00	36.00	29.00	37.00	27.00	25.00	22.00	26.00	19.00	24.00	23.00	22.00	21.00	18.00	18.00	20.00	15.00	13.00	13.00
Shareholder's Equity	3.5%	234	226	204	199	194	192	178	175	172	170	157	151	140	134	115	108	110	111	97.00	89.00	103
Retained Earnings	-0.9%	-407	-403	-416	-412	-407	-399	-405	-399	-390	-383	-387	-382	-379	-375	-388	-391	-383	-378	-388	-391	-371
Shares Outstanding	1.4%	48.00	48.00	48.00	48.00	48.00	47.00	47.00	47.00	47.00	46.00	47.00	46.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	1,775	-	-	-	1,179	-	-	-	2,431	-	-	-	618	-	-	-	828	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-28.6%	7,202	10,086	7,169	10,196	7,860	6,975	4,101	3,143	3,468	10,551	3,634	4,769	10,086	11,337	4,570	-3,021	4,686	3,150	7,892	-18,379	154
Share Based Compensation	42.3%	9,834	6,909	7,924	8,761	8,731	7,740	9,104	10,808	9,531	7,841	8,596	10,866	7,019	3,024	2,675	4,376	3,768	3,084	3,285	4,182	2,628
Cashflow From Investing	-214.7%	-25,452	-8,088	4,566	-2,408	2,800	-21,729	-811	-2,997	-10,669	1,885	-2,629	-14,943	12,186	-25,678	-17,436	12,212	13,742	-14,604	13,368	-3,811	15,662
Cashflow From Financing	62.7%	2,126	1,307	1,009	1,195	107	605	-312	249	503	1,341	1,787	3,781	2,262	4,454	791	890	306	1,527	1,683	1,068	982

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

VCEL Income Statement

2024-03-31

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Product sales, net	$ 51,281	$ 41,017
Total revenue	51,281	41,017
Cost of product sales	15,927	14,497
Gross profit	35,354	26,520
Research and development	6,418	5,212
Selling, general and administrative	34,400	29,485
Total operating expenses	40,818	34,697
Loss from operations	(5,464)	(8,177)
Other income (expense):
Interest income	1,762	839
Interest expense	(153)	(145)
Other expense	(7)	(12)
Total other income	1,602	682
Net loss	$ (3,862)	$ (7,495)
Net loss per common share:
Basic (in USD per share)	$ (0.08)	$ (0.16)
Diluted (in USD per share)	$ (0.08)	$ (0.16)
Weighted-average common shares outstanding:
Basic (in shares)	48,141	47,387
Diluted (in shares)	48,141	47,387
Revenue, Product and Service [Extensible List]	Product [Member]	Product [Member]
Cost, Product and Service [Extensible List]	Product [Member]	Product [Member]

VCEL Balance Sheet

2024-03-31

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 62,938	$ 69,088
Restricted cash	7,804	17,778
Short-term investments	47,710	40,469
Accounts receivable (net of allowance for doubtful accounts of $87 and $43, respectively)	49,934	58,356
Inventory	13,557	13,087
Other current assets	7,775	6,853
Total current assets	189,718	205,631
Property and equipment, net	56,392	41,635
Intangible assets, net	6,719	6,875
Right-of-use assets	73,682	73,462
Long-term investments	29,433	25,283
Other long-term assets	717	771
Total assets	356,661	353,657
Current liabilities:
Accounts payable	19,432	22,347
Accrued expenses	11,026	17,215
Current portion of operating lease liabilities	6,012	6,187
Total current liabilities	36,470	45,749
Operating lease liabilities	86,141	81,856
Other long-term liabilities	154	100
Total liabilities	122,765	127,705
COMMITMENTS AND CONTINGENCIES (Note 12)
Shareholders’ equity:
Common stock, no par value; shares authorized — 75,000; shares issued and outstanding — 48,489 and 47,829, respectively	641,180	629,229
Accumulated other comprehensive loss	(245)	(100)
Accumulated deficit	(407,039)	(403,177)
Total shareholders’ equity	233,896	225,952
Total liabilities and shareholders’ equity	$ 356,661	$ 353,657

About Vericel Corp

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

CEO	Mr. Dominick C. Colangelo Esq.
WEBSITE	https://vcel.com
INDUSTRY	Biotechnology
EMPLOYEES	305

Vericel Corp Frequently Asked Questions

What is the ticker symbol for Vericel Corp? What does VCEL stand for in stocks?

VCEL is the stock ticker symbol of Vericel Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Vericel Corp (VCEL)?

As of Mon May 13 2024, market cap of Vericel Corp is 2.36 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of VCEL stock?

You can check VCEL's fair value in chart for subscribers.

What is the fair value of VCEL stock?

You can check VCEL's fair value in chart for subscribers. The fair value of Vericel Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Vericel Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for VCEL so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Vericel Corp a good stock to buy?

The fair value guage provides a quick view whether VCEL is over valued or under valued. Whether Vericel Corp is cheap or expensive depends on the assumptions which impact Vericel Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for VCEL.

What is Vericel Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon May 13 2024, VCEL's PE ratio (Price to Earnings) is 5.71 Thousand and Price to Sales (PS) ratio is 11.35. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. VCEL PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Vericel Corp's stock?

In the past 10 years, Vericel Corp has provided 0.285 (multiply by 100 for percentage) rate of return.